Please note: The information displayed on this page might be outdated.
Cerebral Therapeutics: Provider of combination therapies intended to improve the lives of patients with uncontrolled neurological diseases. The company's therapies utilize reformulated off-patent drugs delivered to the ventricles of the brain in order to bypass the blood-brain barrier, enabling its clients to receive a reliable approach of treating neurological diseases for which oral infused medicines are not able to achieve adequate control.
US - Mountain
Company Participants at Fall Private Company Showcase 2020
Cerebral Therapeutics, Chief Executive Officer
Dr. Abrams is the Chief Executive Officer and a Member of the Board of Directors of Cerebral Therapeutics™. Prior to founding Cerebral Therapeutics™, Dr. Abrams founded Sierra Neuropharmaceuticals, Inc.; raising $21.5 million in Series A venture capital. Dr. Abrams has practiced as a neurosurgeon and a psychiatrist and served as head of the Department of Neurosurgery at St. Joseph’s Hospital in Denver. Dr. Abrams’ expertise with implantable CNS infusion pumps, experience in cerebrospinal fluid drug delivery and in the use and development of CNS pharmaceutics makes him well suited to lead Cerebral Therapeutics™ development of implantable infusion systemic medications for patients with severe medically refractory epilepsy.
Cerebral Therapeutics, President/COO
Since Jul 2019 John is President of Cerebral Therapeutics. Prior he was President at NeuroBridge for over 2 years. Before that he was President at InnerSpace Neuro. He remains Member of the Board at SpineThera and Gillette Children's Specialty Healthcare. John studied at the University of Minnesota.